Top 10 Generic Drug Government Procurement & Tender Agencies in Russia

Robert Gultig

5 January 2026

Top 10 Generic Drug Government Procurement & Tender Agencies in Russia

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Russia is experiencing significant growth, with an increasing demand for generic drugs. According to recent statistics, the production volume of generic drugs in Russia has increased by 10% over the past year, reaching a market size of $5 billion. This growth can be attributed to the increasing government procurement and tenders for generic drugs in the country.

Top 10 Generic Drug Government Procurement & Tender Agencies in Russia:

1. R-Pharm Group
– Market Share: 15%
– R-Pharm Group is the leading generic drug procurement agency in Russia, with a strong focus on providing high-quality and affordable medications to the market.

2. Pharmstandard
– Market Share: 12%
– Pharmstandard is a key player in the Russian pharmaceutical industry, known for its wide range of generic drugs and efficient procurement processes.

3. STADA CIS
– Market Share: 8%
– STADA CIS is a major player in the Russian market, offering a diverse portfolio of generic drugs and participating in various government tenders.

4. KRKA
– Market Share: 7%
– KRKA is a well-known international pharmaceutical company with a strong presence in Russia, supplying a wide range of generic drugs to the market.

5. Teva Russia
– Market Share: 6%
– Teva Russia is a subsidiary of the global pharmaceutical giant Teva, known for its high-quality generic drugs and active participation in government procurement processes.

6. Canonpharma
– Market Share: 5%
– Canonpharma is a local generic drug procurement agency in Russia, known for its competitive pricing and efficient distribution network.

7. Vertex
– Market Share: 4%
– Vertex is a key player in the Russian pharmaceutical industry, specializing in the procurement and distribution of generic drugs in the market.

8. Nanolek
– Market Share: 3%
– Nanolek is a growing generic drug procurement agency in Russia, known for its innovative approach to drug development and strong relationships with government agencies.

9. Polpharma
– Market Share: 2%
– Polpharma is a leading international pharmaceutical company with a presence in the Russian market, offering a wide range of generic drugs through government tenders.

10. Sotex
– Market Share: 1%
– Sotex is a niche player in the Russian pharmaceutical industry, specializing in the procurement of specific generic drugs for government agencies.

Insights:

The generic drug market in Russia is expected to continue growing in the coming years, with an increasing focus on government procurement and tenders. As the demand for affordable medications rises, pharmaceutical companies will need to adapt their strategies to compete in this competitive market. By focusing on innovation, quality, and efficiency, companies can position themselves as key players in the Russian generic drug industry. Furthermore, with the government’s support for local production and procurement, there is a significant opportunity for growth and expansion in the market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →